Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_1
1
20%
Ph not_applicable
1
20%
Ph phase_4
1
20%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

completed360%
terminated120%
unknown120%

Recent Activity

0 active trials
Showing 5 of 5
completed

The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin Hormones

NCT02360878
completednot_applicable

Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal Liner

NCT01114438
terminated

Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or Obesity

NCT03072901
completedphase_1

A Study of the GI Sleeve for the Treatment of Type 2 Diabetes

NCT02709577
unknownphase_4

EndoBarrier Versus Intragastric Balloon in Obese Diabetic Patients

NCT01848795

Clinical Trials (5)

Showing 5 of 5 trials
NCT02360878

The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin Hormones

Completed
NCT01114438Not Applicable

Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal Liner

Completed
NCT03072901

Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or Obesity

Terminated
NCT02709577Phase 1

A Study of the GI Sleeve for the Treatment of Type 2 Diabetes

Completed
NCT01848795Phase 4

EndoBarrier Versus Intragastric Balloon in Obese Diabetic Patients

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5